The demand for women’s healthcare products has grown steadily across India due to increased awareness, improved diagnosis, and greater access to gynecological care. As a result, the gynae PCD pharma franchise in India has emerged as one of the most stable and high-growth opportunities for pharmaceutical distributors and entrepreneurs.
Gynecology products cover a wide range of therapeutic areas including menstrual health, infections, infertility support, pregnancy care, hormonal balance, and postnatal recovery. With consistent prescriptions and long-term patient usage, gynae formulations offer strong repeat business potential.
Kroyf Labs provides a professionally managed gynae PCD pharma franchise in India, offering quality-driven products, ethical business practices, and long-term franchise support
| Sr.No. | Brand Name | Dosage Form | Composition | Pack |
|---|---|---|---|---|
| 1 | Kaprion | Tablet | Tranexamic acid 500 mg | 10*10 Alu-Alu |
| 2 | Tranzic ET | Tablet | Tranexamic Acid 250 mg+ Etamsylate 250mg | 10*10 Alu-Alu |
| 3 | Tranzic Plus | Tablet | Tranexamic acid 500 mg + Mefenamic acid 250mg | 10*10 Alu-Alu |
| 4 | Depomate 10 | Tablet | Medroxy Progesterone Acetate 10 Mg. | 10*10 Alu-Alu |
| 5 | Doxytick | Tablet | Doxylamine Succinate 10 mg + Pyridoxine hydrochloride 10 mg + Folic Acid 2.5 MG | 10*10 BLI |
| 6 | Doxytick Extra | Tablet | Doxylamine Succinate 20 mg + L-Methylfolate Calcium 1 mg + Pyridoxal 5-Phosphate 10 mg + Mecobalamin 1500 mg | 10*10 Strip pack |
| 7 | Kefmist | Tablet | Combikit of 1 Tab Fluconazole 150mg + 1 Tab Azithromycin 1gm + 2 Tabs Secnidazole 1gm | 10 Kits |
| 8 | Irolyn | Tablets | Ferrous Ascorbate 100mg + Folic Acid 1.5mg+ Zinc 7.5mg | 10*1*10 |
| 9 | Irolyn | Syrup | Ferrous Ascorbate 30mg,Folic Acid 500 mcg | 150ml. With Carton |
| 10 | Irolyn Extra | Soft Gelatin Capsule | Ferrous Ascorbate 100mg + Folic Acid 1.5mg + Vitamin D3 1000 IU + Vitamin B12 7.5 mcg + Vitamin B6 1.5 mg | 10*10 Alu-Alu |
| 11 | Dydrotip | Tablet | Dydrogesterone 10 mg | 10*1*10 Blister |
| 12 | Metadyn | Tablet | Methylcobalamin 1500 Mcg + L-5-Methyl-Tetrahydrofolate Eq. To L-Methylfolate 1 mg+Pyridoxal-5-Phosphate 0.5 mg | 10*10 Alu-Alu |
| 13 | Metadyn Plus | Soft Gelatin Capsule | L-Methylfolate 1 mg + Docosahexaenoic Acid (DHA) 40 % 200 mg + Pyridoxal-5 Phosphate 0.5 mg+ Methylcobalamin 1500 mcg + Vitamin D3 2000 IU Excipients q.s | 10*1*10 |
| 14 | Metadyn DHA | Soft Gelatin Capsule | Methylcobalamin 1500 MCG + Folic Acid 5mg + DHA 200 mg+ vit. B6 1.5mg Prenatal Soft Gelatin Capsule | 10*1*10 |
| 15 | Fosmol | Sachet | Fosfomycin Trometamol 5.6 MG equivalent to 3 mg | 10*1*8 gm |
| 16 | Kefcore Max | Soft Gelatin Capsule | Coral Calcium 225 Mg + Methylcobalamin 1500 Mcg + Vit. B6 3 Mg+ Vitamin D3 250 Iu +Folic Acid 1.5 Mg (DRUG) | 10*1*10 |
| 17 | Norefem 5 | Tablet | Norethisterone 5mg | 10*10 BLI |
| 18 | Norefem 10 CR | Tablet | Norethisterone Acetate 10 mg Controlled Release | 10*10 Alu-Alu |
| 19 | Ovival Plus | Tablet | Myo-inositol 1.1 Gm +D-Chiro-inositol 27.6 Mg+ L-Methylfolate calcium 200 mcg+ Vitamin D3 400 Iu | 10*10 Alu-Alu |
| 20 | Pregrez 100 | Soft Gelatin Capsule | Natural Micronised Progesterone 100mg | 10*1*10 |
| 21 | Pregrez 200 | Soft Gelatin Capsule | Natural Micronised Progesterone 200mg | 10*1*10 |
| 22 | Pregrez 200 SR | Tablet | Natural Micronised Progesterone 200mg SR | 10*10 Alu-Alu |
| 23 | Pregrez 300 SR | Tablet | Natural Micronised Progesterone 300mg SR | 10*10 Alu-Alu |
| 24 | VIXELO SUPER | Tablet | Multivitamin, Multimineral & Grape Seed Extract | 10*15 Alu-Alu |
| 25 | Drotox M | Tablet | Drotaverine 80 mg +Mefenamic Acid 250mg | 10*10 BLI |
| 26 | Claudis Cl | Soft Gelatin Capsule | Clindamycin phosphate 100 mg + Clotrimazole 200 mg Vaginal Soft Gelatin Capsule | 10*1*7 BLI |
| 27 | Claudis TZ | Soft Gelatin Capsule | Clindamycin Phosphate Equivalent To Clindamycin 100 Mg + Clotrimazole 100 Mg +Tinidazole 100mg | 10*1*7 Bli |
| 28 | Zargyn A9 | Sachet | L-Arginine IP 3 gm + Proanthocyanidin 75 mg | 10 sachet |
Send Your Enquiry
Growing Demand for Gynecology Medicines in India
According to the Ministry of Health and Family Welfare (MoHFW), women’s reproductive health is a national priority under various healthcare programs. Increased focus on maternal health, anemia control, menstrual hygiene, and reproductive wellness has significantly boosted demand for gynecology medicines.
Authoritative sources such as the World Health Organization (WHO) emphasize the importance of access to safe, effective, and quality-assured gynecological medicines for improving women’s health outcomes.
Reference:
https://www.who.int/health-topics/sexual-and-reproductive-health
This sustained demand makes the gynae PCD pharma franchise in India a commercially viable and future-ready segment.
What Is a Gynae PCD Pharma Franchise?
A gynae PCD pharma franchise allows distributors to market gynecology products under a company’s brand name within an allotted territory. Under this model, the franchise partner benefits from:
- Monopoly rights in a defined area
- Ready-to-sell gynecology product range
- Established branding and product support
- Reduced investment risk
- Scalability and long-term growth
For professionals seeking a focused and ethical pharma business, a gynae PCD pharma franchise in India offers predictable demand and strong doctor connectivity.
Key Product Categories in a Gynae PCD Franchise
A well-structured gynae portfolio should address multiple therapeutic needs. Leading providers of a gynae PCD pharma franchise in India typically include products such as:
- Iron, folic acid & anemia management formulations
- Menstrual regulation and hormonal balance products
- Antifungal and antibacterial gynecology medicines
- Pregnancy care and prenatal supplements
- Lactation and postnatal support formulations
- PCOS and reproductive health support products
These categories align with clinical treatment guidelines and ensure consistent prescription flow.
Regulatory Standards for Gynecology Medicines in India
Gynecology medicines are regulated as per the Drugs & Cosmetics Act, 1940, and overseen by the
Central Drugs Standard Control Organization (CDSCO), Government of India.
Official portal:
https://cdsco.gov.in/opencms/opencms/en/Home/
Manufacturing facilities supplying gynae medicines are required to follow Good Manufacturing Practices (GMP) as defined by the World Health Organization (WHO).
WHO GMP reference:
https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/gmp
Additionally, quality benchmarks are outlined by the Indian Pharmacopoeia Commission (IPC), which defines standards for pharmaceutical ingredients and finished formulations.
https://ipc.gov.in/
Partnering with a compliant gynae PCD pharma franchise in India ensures safety, consistency, and regulatory acceptance.
Why Quality Matters in Gynae Products
Gynecology medicines directly impact women’s reproductive and hormonal health. Regulatory authorities stress the importance of:
- Consistent formulation accuracy
- Stability and bioavailability
- Controlled raw material sourcing
- Proper labeling and documentation
- Pharmacovigilance and batch traceability
As highlighted by WHO reproductive health guidelines, quality-assured medicines are critical for patient safety and therapeutic success.
Why Choose Kroyf Labs for Gynae PCD Pharma Franchise in India
Among companies offering a gynae PCD pharma franchise in India, Kroyf Labs focuses on quality-first manufacturing and transparent franchise partnerships.
Kroyf Labs offers:
- WHO-GMP compliant manufacturing facilities
- Carefully curated gynecology product range
- Monopoly-based franchise opportunities
- Competitive pricing for sustainable margins
- Reliable supply chain and timely dispatch
- Ethical marketing and professional support
Rather than aggressive expansion, Kroyf Labs prioritizes consistency, regulatory compliance, and long-term partner success — making it a dependable choice in the gynae segment.
Premium-Quality Gynae Products With Practical Business Value
In a market where product quality directly impacts doctor confidence and repeat prescriptions, Kroyf Labs follows a premium-quality manufacturing approach while keeping pricing practical for long-term business growth.
Many of our gynae formulations are manufactured at facilities that also cater to established and well-known pharmaceutical brands, ensuring the same regulatory discipline, quality controls, and formulation standards — without inflated branding costs. This allows Kroyf Labs to offer premium-grade gynecology products at competitive, partner-friendly pricing.
With a portfolio of 30+ gynae products, our range is designed to cover multiple therapeutic needs while allowing franchise partners to build a comprehensive and scalable women’s healthcare portfolio under one trusted brand.
This balance of quality parity with leading brands and cost efficiency for distributors makes Kroyf Labs a strong choice for professionals seeking a reliable gynae PCD pharma franchise in India.
Exclusive Monopoly Rights Across States and Districts
Kroyf Labs offers exclusive monopoly rights for both state-wise and district-wise territories, ensuring our franchise partners can operate without internal competition.
This structured approach allows partners to:
- Build long-term doctor relationships
- Strengthen brand recall in their region
- Invest confidently in promotions
- Scale operations systematically
Monopoly allocation is done transparently, with clear territory mapping to support sustainable growth under the gynae PCD pharma franchise in India model.
Who Can Apply for a Gynae PCD Pharma Franchise?
A gynae PCD pharma franchise in India is suitable for:
- Pharma distributors
- Medical representatives
- Healthcare entrepreneurs
- Existing PCD franchise holders
- Pharma companies expanding into women’s healthcare
Minimal investment, combined with consistent demand, makes this segment ideal for both new and experienced professionals.
Business Advantages of Gynae PCD Pharma Franchise in India
Choosing a gynae-focused PCD franchise offers multiple advantages:
- High doctor engagement
- Strong repeat prescription cycle
- Long-term patient usage
- Wide therapeutic relevance
- Scalable portfolio expansion
With increasing awareness of women’s health, the gynae PCD pharma franchise in India remains one of the most resilient pharma business models.
Storage, Handling & Quality Assurance
Gynecology products must be stored and handled according to label instructions to maintain stability and efficacy. WHO and IPC guidelines emphasize:
- Controlled storage conditions
- Protection from heat and moisture
- Proper inventory rotation
- Documentation and traceability
Kroyf Labs follows these best practices to ensure product integrity.
Frequently Asked Questions (FAQs)
What is a gynae PCD pharma franchise in India?
It is a business model where a pharma company allows distributors to market gynecology products under its brand with monopoly rights in a specific territory.
Why is the gynae segment profitable?
Gynecology medicines have consistent demand due to menstrual health, pregnancy care, infections, and hormonal treatments, resulting in repeat prescriptions.
Are gynae medicines regulated in India?
Yes. Gynae medicines are regulated by the Central Drugs Standard Control Organization (CDSCO) under the Drugs & Cosmetics Act, 1940.
Why is WHO-GMP important for gynae products?
Does Kroyf Labs offer monopoly rights?
WHO-GMP ensures medicines are manufactured under controlled conditions, ensuring safety, quality, and consistency — especially critical for women’s health products.
Does Kroyf Labs offer monopoly rights?
Yes, Kroyf Labs provides monopoly-based franchise opportunities to support focused territory growth and reduce internal competition.
Conclusion
The gynae PCD pharma franchise in India offers a stable, ethically aligned, and growth-oriented opportunity in today’s pharmaceutical landscape. With rising awareness of women’s health and strong regulatory oversight, quality-focused gynecology products continue to see long-term demand.
By partnering with Kroyf Labs, franchise associates gain access to a professionally managed gynae portfolio, regulatory-compliant manufacturing, and dependable business support — laying the foundation for sustainable success.
Start Your Gynae PCD Pharma Franchise in India With Kroyf Labs
If you are looking to partner with a quality-focused, professionally managed gynae PCD pharma franchise in India, Kroyf Labs offers the right blend of premium manufacturing standards, exclusive monopoly rights, and long-term business support.
With a portfolio of 30+ gynecology products, state and district-level monopoly availability, and a compliance-driven approach, we help our partners build a stable and scalable pharma business.
👉 Contact us today to explore franchise availability, product details, and partnership opportunities.
